“We are proud to support the cutting-edge research being done at the six LABS program sites.” - August Schiesser, Executive Director, Warren Alpert Foundation
💜 #NationalCancerResearchMonth #NCRM #ResearchIsFundamental
lustgarten.org/the-lustgarten…

Lustgarten's 'Faces of Discovery' campaign, in celebration of #NationalCancerResearchMonth , is bringing the incredible scientists who are boldly driving progress in #pancreaticcancer research to YOU! Meet Tracy W. Liu, PhD, assistant professor, WVU School of Medicine
AACR

.Stand Up To Cancer- @Lustgartenfdn Convergence® Team Co-Leader Benjamin D. Greenbaum of Memorial Sloan Kettering Cancer Center is presenting his work developing a mRNA vaccine for #pancreaticcancer . #StandUpToCancer #SU2CAIInnovationSummit

The final session, about medical records in algorithms, is beginning with a talk from Stand Up To Cancer- @Lustgartenfdn PCC AI Team Leader Dr. Chris Sander of Harvard University about using deep learning algorithms to predict the risk of #pancreaticcancer . #StandUpToCancer #SU2CAIInnovationSummit

Lustgarten-funded researchers are stretching the boundaries of science to produce real results for #pancreaticcancer patients! 🙌 2022 grant recipient, Laura Wood, MD, PhD, Johns Hopkins Kimmel Cancer Center, was published in nature. Check it out💜 #ResearchIsFundamental lfdn.org/4bjvwkD

This #NationalCancerResearchMonth , we are shining a spotlight on our 'Faces of Discovery' - Lustgarten-funded scientists who are boldly driving progress in #pancreaticcancer research! 💜 Meet Christina G. Towers, PhD, @Salk.
AACR #ResearchIsFundamental #LedByLustgarten

A huge THANK YOU to all of our wonderful volunteers! 💜
YOU can inspire hope by volunteering at a Lustgarten event - sign up today! lustgarten.org/volunteer/
#NationalVolunteersWeek #CommunityIsPower

Congratulations to David Tuveson, M.D., Ph.D., Lustgarten's Chief Scientist, on being elected to the American Academy of Arts and Sciences!

#ICYMI - Elliot Newman, MD, chief of surgical oncology @ Lenox Hill Hospital & one-year #pancreaticcancer survivor, Jeneen Genna, were on @CBSNY! Both will be at this Sunday's NYC Walk for Research, sponsored by Northwell Health! Lustgarten.org/NYC
#CommunityIsPower #PCWalk

A9.1 The FELIX program has successfully developed highly accurate algorithms capable of identifying pancreatic cancer lesions with an accuracy rate of over 90%. #PancChat

A8.2 The Pancreatic Cancer Early Detection (PRECEDE) Consortium established a cohort of individuals with family history of PDAC and/or individuals carrying pathogenic germline variants (PGVs) in genes linked to PDAC risk. clinicaltrials.gov/study/NCT04970… #PancChat

A8.1 The Cancer of the Pancreas Screening-5 CAPS5)Study, launched in 2014, emphasizes the critical need for regular imaging surveillance among high-risk individuals. This is a longitudinal study that follows high-risk patients for 10 years. clinicaltrials.gov/study/NCT02000… #PancChat

A7.1 Investigators in the NCI's Early Detection Research Network (EDRN) and Pancreatic Cancer Detection Consortium (PCDC) have identified many candidate biomarkers, using technologies such as next generation DNA sequencing and radiomics. #PancChat

A6.2 The Lustgarten Foundation has funded The FELIX Program since 2016. The program essentially uses data from thousands of Computer Tomography (CT) scans to teach computers to detect tumors small enough to be missed by even the most experienced radiologists. #PancChat

A6.1 Artificial Intelligence is currently being developed for a wide variety of detection and treatment related applications for pancreatic cancer. #PancChat

A5.2 More challenges include the pancreas’ location deep in the abdomen and the delayed onset of pancreatic cancer symptoms. #PancChat

A5.1 Standard imaging often fails to identify a majority of small pancreatic cancers because of subtle imaging features, inadequate attention to the pancreas or technical inadequacies. #PancChat

A4.3 Other project goals include identifying targets & therapeutic approaches for disease interception and prevention, clinically testing interception, & optimizing biomarkers enabling early detection in the general population. #PancChat

A4.2 These projects aim to understand the biology of early pancreatic cancer and pre-cancers, develop tools for improved risk assessment and identification of high-risk groups, & identify biomarkers and imaging approaches for PC. #PancChat

A4.1 There are detection and interception research projects taking place funded by Lustgarten. #PancChat